^
BIOMARKER:
CD20 positive
i
Other names: CD20, MS4A1, Membrane Spanning 4-Domains A1, Membrane-Spanning 4-Domains, Subfamily A, Member 1, Leukocyte Surface Antigen Leu-16, B-Lymphocyte Antigen CD20, CD20 Antigen, Membrane-Spanning 4-Domains Subfamily A Member 1, B-Lymphocyte Cell-Surface Antigen B1, B-Lymphocyte Surface Antigen B1, CD20 Receptor, LEU-16, CVID5, MS4A2
Entrez ID:
Related biomarkers:
CD20 positive
CLL
Truxima (rituximab biosimilar)
Sensitive
:
A1
CD20 positive
Diffuse Large B Cell Lymphoma
Rixathon (rituximab biosimilar)
Sensitive
:
A1
CD20 positive
Diffuse Large B Cell Lymphoma
Truxima (rituximab biosimilar)
Sensitive
:
A1
CD20 positive
Diffuse Large B Cell Lymphoma
Ruxience (rituximab biosimilar)
Sensitive
:
A1
CD20 positive
Follicular Lymphoma
rituximab + ibritumomab tiuxetan
Sensitive
:
A1
CD20 positive
CLL
rituximab
Sensitive
:
A1
CD20 positive
NHL
rituximab
Sensitive
:
A1
CD20 positive
CLL
Ruxience (rituximab biosimilar)
Sensitive
:
A1
CD20 positive
Follicular Lymphoma
Ruxience (rituximab biosimilar)
Sensitive
:
A1
CD20 positive
ALL
rituximab
Sensitive
:
A2
CD20 positive
NHL
rituximab + copanlisib
Sensitive
:
B
CD20 positive
Follicular Lymphoma
Truxima (rituximab biosimilar)
Sensitive
:
C1
CD20 positive
Diffuse Large B Cell Lymphoma
GEN3013
Sensitive
:
C2
CD20 positive
Follicular Lymphoma
GEN3013
Sensitive
:
C2
CD20 positive
CLL
FCR
Sensitive
:
C3
CD20 positive
Diffuse Large B Cell Lymphoma
venetoclax + obinutuzumab
Sensitive
:
C3
CD20 positive
NHL
rituximab + ALX148
Sensitive
:
C3
CD20 positive
B Acute Lymphoblastic Leukemia
blinatumomab
Sensitive
:
C3
CD20 positive
NHL
rituximab + PF-05082566
Sensitive
:
C3
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our